Abbott pays $1.6 billion to settle Depakote claims
May 8, 2012Medical Communications, Sales and Marketing AbbVie, Abbott, CIA, Depakote
Abbott will pay $1.6 billion to settle US legal claims over its epilepsy drug Depakote. The $1.6 billion will settle …
UK government launches lung cancer awareness campaign
May 8, 2012Medical Communications Cancer, UK, government, lung
The UK government has launched a new lung cancer awareness campaign backed by a number of celebrities. Ricky Gervais and …
Auto Injectors: Addressing Proper Self-administration Needs with Training Devices
May 8, 2012Manufacturing and Production
As the demand for biologics continues to increase, corresponding growth for advanced drug delivery devices such as auto injectors can …
Former Novartis man becomes GSK’s new medical director
May 8, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Shannon, Novartis
James Shannon has been named GSK’s chief medical officer, and will report to R&D chairman Moncef Slaoui. He will be …
Roche abandons Phase III cholesterol drug
May 8, 2012Medical Communications, Research and Development, Sales and Marketing CETP inhibitor, Roche, cardiovascular, dalcetrapib, phase III failure
Roche has abandoned its Phase III cholesterol treatment dalcetrapib after disappointing results.The manufacturer is ceasing work on the drug, once …
Teva launches first generic Lipitor in UK
May 8, 2012Sales and Marketing Lipitor, NHS, Pfizer, Teva, atorvastatin
Teva has launched the first generic Lipitor in the UK on the day the drug loses its patent protection. The …
Novartis ponders Lucentis price cut in UK
May 8, 2012Medical Communications, Sales and Marketing Lucentis, NICE, avastin, market access
Novartis could cut the price of its eye drug Lucentis in the UK to head off moves to switch patients …
BASF to build plant in US
May 8, 2012Manufacturing and Production BASF, Taylor, manufacturing, production
BASF has said it plans to build a new manufacturing facility for formic acid at its production site in Louisiana, …
DSM sees green shoots for pharma unit in Q1
May 8, 2012Business Services, Manufacturing and Production, Sales and Marketing DSM, Kensey Nash, NSCLC, Q1, Sinochem
DSM said its pharmaceutical business unit posted ‘weak’ financials in the first quarter of 2012, although revenues rose and there …
Genzyme boosts capacity following green light for Waterford plant
May 8, 2012Manufacturing and Production EMA, FDA, Genzyme, Sanofi, Waterford
Sanofi subsidiary Genzyme has doubled its capacity to fill-and-finish two of its drugs for rare disorders following approval of a …
ABPI to help pharma with digital communications
May 4, 2012Medical Communications ABPI, Code breach, PMCPA, Shire, digital, pharma
The ABPI has set up a new group to help pharma with its online communications. The UK industry body said …
GSK signs deal with academics
May 4, 2012Research and Development, Sales and Marketing Cancer, GSK, PROTAC, Yale, academia
GlaxoSmithKline has forged another link with academia, signing a deal with Yale University to design a potential new class of …
David Colin Thomé named as new Primary Care Commissioning chair
May 4, 2012Business Services, Sales and Marketing NHS, PCC
Primary Care Commissioning (PCC) has appointed David Colin Thomé as chair with immediate effect. Professor Thomé was until recently …
Novartis to acquire Fougera for $1.5 billion
May 3, 2012Sales and Marketing Fougera, Novartis, dermatology, generics, gilenya
Novartis will acquire the dermatology generics firm Fougera for $1.53 billion in cash. Novartis’ generic unit Sandoz is conducting the …
Roche and Novartis have best websites
May 3, 2012Medical Communications Bowen Craggs & Co, Novartis, Pfizer, Roche, Shell, digital, web
A new survey of leading international companies has found Roche and Novartis have the best websites in the pharma sector. …
GSK appoints two non-executive directors to its Board
May 3, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Jing Ulrich, Lynn Elsenhans
GlaxoSmithKline has announced that Lynn Elsenhans and Jing Ulrich will join the Board of the Company with effect from 1 …
Oxford BioTherapeutics appoints new chief operations officer
May 3, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Oxford Biotherapeutics
Oxford BioTherapeutics (OBT) has appointed Dr Esteban Pombo-Villar as its new chief operations officer (COO). In this position he will …
Pfizer enters Gaucher disease market
May 3, 2012Sales and Marketing Cerezyme, Elelyso, Gaucher, Genzyme, Pfizer, Shire, Vpriv
Pfizer has gained FDA approval for its new Gaucher disease drug Elelyso. Elelyso (taliglucerase alfa) is an enzyme replacement therapy …
Professional regulation – a DIY job?
May 2, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPD, GMC, Les Rose, drug discovery, regulation
What would happen if we had no drug regulatory bodies, such as the MHRA and the EMA? Can you imagine …
Lilly invests in UK research base
May 2, 2012Research and Development Elil Lilly, Erl Wood, neuroscience
Eli Lilly has officially opened new research facilities at its R&D base in Erl Wood in Surrey.The site near Woking …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
